SOPHiA GENETICS Showcases Advancements in Cancer Care at ESMO 2024

SOPHiA GENETICS Unveils SOPHiA UNITY Updates at ESMO 2024

SOPHiA GENETICS, a leading health tech company, has announced significant updates to its SOPHiA UNITY platform at the European Society for Medical Oncology (ESMO) 2024 Congress. The company is set to showcase these advancements, which aim to revolutionize cancer care through precision medicine 1

1

Key Features of SOPHiA UNITY

SOPHiA UNITY is an innovative platform designed to provide a comprehensive view of a patient's cancer profile. The platform integrates various data types, including genomics, radiomics, and clinical data, to offer actionable insights for personalized treatment strategies. This holistic approach enables healthcare professionals to make more informed decisions in cancer care 1

1

Poster Presentations Highlighting Clinical Utility

In addition to the platform updates, SOPHiA GENETICS will present two posters at ESMO 2024, demonstrating the clinical utility of their technology:

1. "Comprehensive genomic profiling using SOPHiA DDM for Solid Tumor Plus Solution in advanced cancers"
2. "Real-world evidence of comprehensive genomic profiling using SOPHiA DDM for Solid Tumor Plus Solution in advanced cancers"

These presentations will showcase the practical applications and real-world impact of SOPHiA GENETICS' solutions in oncology 2

2

Advancing Precision Medicine in Oncology

The updates to SOPHiA UNITY and the poster presentations underscore SOPHiA GENETICS' commitment to advancing precision medicine in oncology. By leveraging artificial intelligence and machine learning, the company aims to enhance the accuracy and efficiency of cancer diagnosis and treatment planning 1

1

Related Stories

SOPHiA GENETICS Unveils Groundbreaking AI-Driven Patient Stratification Research at ESMO 2024

SOPHiA GENETICS Expands Partnership with Canadian Oncology Lab OncoHelix

Precision for Medicine and SOPHiA GENETICS Partner to Enhance AI-Driven Biomarker Discovery and Clinical Trials

SOPHiA GENETICS Schedules Q2 2024 Financial Results Announcement

Collaboration with Healthcare Professionals

SOPHiA GENETICS emphasizes the importance of collaboration with healthcare professionals in developing and refining their technologies. The company's presence at ESMO 2024 provides an opportunity for engagement with oncologists, researchers, and other stakeholders in the field of cancer care 2

2

Future Implications for Cancer Treatment

The advancements presented by SOPHiA GENETICS at ESMO 2024 have significant implications for the future of cancer treatment. By providing more comprehensive and accurate patient profiles, SOPHiA UNITY has the potential to improve treatment outcomes and quality of life for cancer patients worldwide 1

1

2